EUVIMEDEUVIMED entdecken
Crossref

Defining Durability in Somatic Gene Therapy: A Conceptual Framework Separating Vector Persistence, Transgene Expression, Cellular Turnover, and Maintenance of Therapeutic Function

Emily Carter, Robert Mensah, Sophie Laurent

Journal of Biochemical Technology · 2026 · 17 (4) · 14-22

DOI: 10.51847/yqvph3fbt7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical Technology, 2026. Verfasst von Emily Carter und 2 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Carter, E., Mensah, R., & Laurent, S. (2026). Defining Durability in Somatic Gene Therapy: A Conceptual Framework Separating Vector Persistence, Transgene Expression, Cellular Turnover, and Maintenance of Therapeutic Function. Journal of Biochemical Technology, 17(4), 14-22. https://doi.org/10.51847/yqvph3fbt7

Vancouver

Carter E, Mensah R, Laurent S. Defining Durability in Somatic Gene Therapy: A Conceptual Framework Separating Vector Persistence, Transgene Expression, Cellular Turnover, and Maintenance of Therapeutic Function. Journal of Biochemical Technology. 2026;17(4):14-22. doi:10.51847/yqvph3fbt7

BibTeX
@article{Carter2026,
  author = {Carter, Emily and Mensah, Robert and Laurent, Sophie},
  title = {Defining Durability in Somatic Gene Therapy: A Conceptual Framework Separating Vector Persistence, Transgene Expression, Cellular Turnover, and Maintenance of Therapeutic Function},
  journal = {Journal of Biochemical Technology},
  year = {2026},
  volume = {17},
  number = {4},
  pages = {14--22},
  doi = {10.51847/yqvph3fbt7}
}
Kostenlos starten →